or
forgot password
  • cancer clinical trials in saint louis, MO

  • Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
    Saint John's Mercy Medical Center

    Trial Locations
    Saint John's Mercy Medical Center
    Saint Louis Cancer and Breast Institute-South City
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Carcinoma, Hepatocellular, Intrahepatic Cholangiocarcinoma
    Neratinib in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Breast Neoplasms
    Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Adenocarcinoma, Pancreatic Neoplasms
    A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Prostate Cancer
    Genomic Predictors of Decitabine Response in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Leukemia, Myeloid, Acute, Myelodysplastic Syndromes
    Post Operative Adjuvant Therapy De-intensification Trial for Human Papillomavirus-related, p16+ Oropharynx Cancer
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Oropharyngeal Neoplasms
    Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot be Removed by Surgery
    Saint Louis-Cape Girardeau CCOP

    Trial Locations
    Saint Louis-Cape Girardeau CCOP
    Saint John's Mercy Medical Center
    Saint Louis Cancer and Breast Institute-South City
    Childhood Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer, Type 1 Papillary Renal Cell Carcinoma, Type 2 Papillary Renal Cell Carcinoma
    Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed By Surgery
    Saint John's Mercy Medical Center

    Trial Locations
    Saint John's Mercy Medical Center
    Siteman Cancer Center at Washington University
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage III Salivary Gland Cancer, Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage III Verrucous Carcinoma of the Larynx, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IVA Salivary Gland Cancer, Stage IVA Squamous Cell Carcinoma of the Larynx, Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVA Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVA Verrucous Carcinoma of the Larynx, Stage IVA Verrucous Carcinoma of the Oral Cavity, Stage IVB Salivary Gland Cancer, Stage IVB Squamous Cell Carcinoma of the Larynx, Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVB Squamous Cell Carcinoma of the Oropharynx, Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVB Verrucous Carcinoma of the Larynx, Stage IVB Verrucous Carcinoma of the Oral Cavity, Stage IVC Salivary Gland Cancer, Stage IVC Squamous Cell Carcinoma of the Larynx, Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVC Squamous Cell Carcinoma of the Oropharynx, Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVC Verrucous Carcinoma of the Larynx, Stage IVC Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Bortezomib Based Consolidation in Multiple Myeloma Patients Completing Stem Cell Transplant
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Cabozantinib in Treating Younger Patients With Recurrent or Refractory Solid Tumors
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Recurrent Melanoma, Recurrent Thyroid Cancer, Thyroid Gland Medullary Carcinoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Immunoregulation Of Lung Cancer by Natural Killer Cells
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Lung Cancer
    A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Non-small Cell Lung Cancer(NSCLC)
    Pazopanib Plus Cetuximab for Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Squamous Cell Carcinoma of the Head and Neck
    Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Phase II Trial of Dalantercept to Treat Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
    Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal Cancer
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Colorectal Neoplasms
    PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Breast Neoplasms
    Tivantinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Unspecified Childhood Solid Tumor, Protocol Specific
    Bevacizumab With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Kidney Cancer
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer, Type 1 Papillary Renal Cell Carcinoma, Type 2 Papillary Renal Cell Carcinoma
    Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Cutaneous T-Cell Lymphoma
    Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Off Clamp Randomization
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Renal Cancer, Renal Ischemia
    Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors
    Siteman Cancer Center
    Saint Louis, Missouri 63110
    Chemotherapy-Induced Nausea and Vomiting
    Early Warning System
    Barnes-Jewish Hospital
    Saint Louis, Missouri 63110
    Congestive Heart Failure, Chronic Obstructive Pulmonary Disease, Cancer, Diabetes Mellitus, Obstructive Sleep Apnea
    Microsphere Localization Using PET/MRI in Patients With Liver Disease
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Liver Neoplasms
    Geriatric Assessments in Senior Adults With Multiple Myeloma
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Multiple Myeloma
    Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, Precursor Cell Lymphoblastic Leukemia-Lymphoma
    Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Leukemia, Lymphoma, Paraproteinemias, Multiple Myeloma, Myelodysplastic Syndromes
    Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia in Complete Remission
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Leukemia, Myeloid, Acute
    Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Non-small Cell Lung Cancer, Progression of Non-small Cell Lung Cancer, Non-small Cell Lung Cancer Recurrent
    Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Recurrent Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer
    ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell
    Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Recurrent Adult Hodgkin Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma
    Esophageal Cancer Tissue Banking
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Esophageal Cancer
    Armodafinil in Reducing Cancer-Related Fatigue in Patients With Glioblastoma Multiforme
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Fatigue
    Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Prostate Cancer
    Phase 3 Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy
    Washington University School of Medicine, Division of Endocrinology, Metabolism and Lipid Research
    Saint Louis, Missouri 63110
    Muscular Dystrophy, Duchenne, Muscular Dystrophies, Muscular Disorders, Atrophic, Muscular Diseases, Musculoskeletal Diseases, Neuromuscular Diseases, Nervous System Diseases, Genetic Diseases, X-Linked, Genetic Diseases, Inborn
    Ibrutinib in Treating Patients With Relapsed or Refractory Follicular Lymphoma
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma
    Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma
    Saint John's Mercy Medical Center
    Saint Louis, Missouri 63141
    Epithelial Mesothelioma, Recurrent Malignant Mesothelioma, Sarcomatous Mesothelioma, Stage II Malignant Mesothelioma, Stage III Malignant Mesothelioma, Stage IV Malignant Mesothelioma
    Promoting Smoking Cessation in Carpenters
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Smoking Cessation, Health Behavior, Cancer
    On-site Cytopathology EUS-FNA
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Pancreatic Neoplasms, Pancreatic Cancer
    Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Cervical Cancer, Ovarian Cancer
    Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Endometrial Cancer, Psychosocial Effects of Cancer and Its Treatment
    Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia
    Barnes-Jewish Hospital
    Saint Louis, Missouri 63110
    Leukemia, Lymphoma
    Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed
    Barnes-Jewish Hospital
    Saint Louis, Missouri 63110
    Colorectal Cancer
    Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Cervical Cancer
    Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme
    Veterans Affairs Medical Center - Saint Louis

    Trial Locations
    Veterans Affairs Medical Center - Saint Louis
    Mallinckrodt Institute of Radiology
    St. Louis University Health Sciences Center
    Brain and Central Nervous System Tumors
    SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin's Disease
    Barnes-Jewish Hospital
    Saint Louis, Missouri 63110
    Lymphoma, Psychosocial Effects of Cancer and Its Treatment
    Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer
    Washington University School of Medicine
    Saint Louis, Missouri 63110
    Ovarian Cancer
    Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma
    St. Louis University Health Sciences Center

    Trial Locations
    St. Louis University Health Sciences Center
    CCOP - St. Louis-Cape Girardeau
    Brain and Central Nervous System Tumors
    Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
    Mallinckrodt Institute of Radiology

    Trial Locations
    Mallinckrodt Institute of Radiology
    St. Louis University Health Sciences Center
    Lung Cancer